Home » Topics » BioWorld Science

BioWorld Science
RSS

Warner-Lambert, Pfizer intend to copromote atorvastatin

April 19, 1996

FDA approves new indication for Pravachol

April 19, 1996

ACAT inhibitor reported by Nisshin Flour Milling

April 19, 1996

Human Genome Sciences' research into cathepsin K

April 19, 1996

Fujisawa describes cathepsin L/B inhibitor of fungal origin

April 19, 1996

Cortecs' oral salmon calcitonin shows favorable phase II results

April 19, 1996

Photofrin approved for marketing in France

April 19, 1996

NU-1064 and NU-1076, PARP inhibitors

April 19, 1996

Dipyridamole analogue more potent than parent drug

April 19, 1996

Cancer Research Center, Moscow, presents MDR inhibitors at NCI-EORTC

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 5, 2025.
CMS vows to put more emphasis on MA plans’ prior authorization
BioWorld MedTech
Physicians aren’t the only ones who see prior authorization (PA) practices as a significant problem, but John Brooks, deputy administrator at CMS, told a med tech...
100 days of uncertainty
BioWorld
The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
Associate degree: PTC’s hints of phase II HD efficacy studied
BioWorld
PTC Therapeutics Inc. CEO Matthew Klein said the firm “achieved all we set out to [achieve] in phase II” with PTC-518 in Huntington’s disease (HD), but it wasn’t...